Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy
Human bone marrow-derived mesenchymal stem cells (hBMSCs) are promising candidates for stem cell therapy in clinical trials. Applications of hBMSCs in clinical therapy are limited by cellular senescence due to long-term ex vivo expansion. Metformin, an oral hypoglycemic drug for type 2 diabetes, has...
Saved in:
Main Authors: | Pingting Ye, Lei Feng, Dan Zhang, Ruihao Li, Yixuan Wen, Xiaohan Tong, Shuo Shi, Chunyan Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2023/1429642 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteomic Analysis of Hypoxia-Induced Senescence of Human Bone Marrow Mesenchymal Stem Cells
by: Liping Mai, et al.
Published: (2021-01-01) -
Characterization and Expression of Senescence Marker in Prolonged Passages of Rat Bone Marrow-Derived Mesenchymal Stem Cells
by: Noridzzaida Ridzuan, et al.
Published: (2016-01-01) -
Metformin ameliorates peripheral neuropathy in diabetic rats by downregulating autophagy via the AMPK pathway
by: Fangqin You, et al.
Published: (2025-01-01) -
Bone marrow mesenchymal stem cells derived cytokines associated with AKT/IAPs signaling ameliorate Alzheimer’s disease development
by: Yalan Lu, et al.
Published: (2025-01-01) -
FOXG1 promotes osteogenesis of bone marrow-derived mesenchymal stem cells by activating autophagy through regulating USP14
by: Yiqi Zhang, et al.
Published: (2025-01-01)